logoTry Persana

Kernal Biologics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Kernal Biologics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Kernal Biologics company logo

KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine

Kernal creates mRNA therapies to cure severe diseases including cancer, utilizing its proprietary platform to instruct specific cells on generating their own therapeutics.

HeadquartersCambridge, United States
Team size11-50
Founded2016

What is Kernal Biologics? - Company Overview & Details

Kernal Biologics is Kernal creates mRNA therapies to cure severe diseases including cancer, utilizing its proprietary platform to instruct specific cells on generating their own therapeutics. Founded in 2016, the company is headquartered in Cambridge, United States.

Who Founded Kernal Biologics?

Kernal Biologics was founded by Yusuf Erkul.

Who are the Key Executives at Kernal Biologics? - Leadership Team

Kernal Biologics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Kernal Biologics

Yusuf ErkulCEO

Chief Technology Officer (CTO) of Kernal Biologics

CTO

About Yusuf Erkul - CEO of Kernal Biologics

Yusuf Erkul serves as the Chief Executive Officer of Kernal Biologics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Kernal Biologics Company Details & Key Information

Where is Kernal Biologics located?

Kernal Biologics is headquartered in Cambridge, United States.

How many employees does Kernal Biologics have?

Kernal Biologics has 11-50 employees.

When was Kernal Biologics founded?

Kernal Biologics was founded in 2016.

Kernal Biologics Official Website

How much funding has Kernal Biologics raised?

Kernal Biologics has raised $25 Million across 5 funding rounds. The most recent funding was completed on 2022-07-07.

Funding Overview

Kernal Biologics raised $25 million in Series A funding led by Hummingbird Ventures with participation from Amgen Ventures.

$25 Million
Total Funding Raised
5
Funding Rounds
2022-07-07
Latest Round

Kernal Biologics Funding History

Series A
2022-07-07
$25 Million

Who are the key investors in Kernal Biologics?

Kernal Biologics is backed by 2 key investors including Hummingbird Ventures, Amgen Ventures. These investors focus on Biotechnology, Pharmaceuticals, Healthcare sectors.

Kernal Biologics Investor Overview

2
Key Investors
4
Focus Areas
2
Notable Investments

Complete List of Kernal Biologics Investors

Hummingbird Ventures

Venture capital firm investing in early-stage companies.

Investment Focus
Biotechnology
Pharmaceuticals
Healthcare
Notable Portfolio Companies
Kernal Biologics

Amgen Ventures

Investment arm of Amgen, focused on biotechnology.

Investment Focus
Biotechnology
Biopharmaceuticals
Notable Portfolio Companies
Kernal Biologics

What sectors do Kernal Biologics investors focus on?

The investors backing Kernal Biologics primarily focus on Biotechnology, Pharmaceuticals, Healthcare, Biopharmaceuticals sectors.

Biotechnology
Pharmaceuticals
Healthcare
Biopharmaceuticals

Featured Investor: Hummingbird Ventures

Hummingbird Ventures

Venture capital firm investing in early-stage companies.

Notable Investments: Kernal Biologics

What are Kernal Biologics's future plans?

Kernal Biologics Kernal aims to further develop its mRNA platform for cancer and autoimmune diseases.

Kernal Biologics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Kernal Biologics face?

Kernal Biologics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Kernal Biologics

1

Competition in the biotech sector

2

Regulatory approvals for clinical trials

What opportunities does Kernal Biologics have?

Kernal Biologics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Kernal Biologics

1

Advancements in mRNA technology

2

Potential partnerships for research

Kernal Biologics Strategic Position Summary

Key Focus Areas

Kernal Biologics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Kernal Biologics?

Kernal Biologics has 2 recent news updates covering key business developments and market activities.

Kernal Biologics News Overview

2
Recent Articles
Active
Media Coverage
2025-05-13
Latest Update

What is Kernal Biologics in the news for?

Kernal Biologics is currently featured in news for Kernal Biologics, Inc. attends event Bio€quity Europe. and other significant business developments.

Recent News Articles About Kernal Biologics

Article 1
2025-05-13

Kernal Biologics, Inc. attends event Bio€quity Europe.

Kernal Bio presents its mRNA platform at the Bio€quity Europe 2025 Conference.

kernalbio.com
Read News
Article 2
2022-07-07

Kernal Biologics, Inc. received financing of $25M in Series A on Jul 7th '22.

Kernal Biologics announced the completion of a $25 million Series A financing led by Hummingbird Ventures.

thepharmaletter.com
Read News

Kernal Biologics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Kernal Biologics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Kernal Biologics Questions & Answers - Company Information

Q1

What is Kernal Biologics?

Kernal creates mRNA therapies to cure severe diseases including cancer, utilizing its proprietary platform to instruct specific cells on generating their own therapeutics.

Q2

Who founded Kernal Biologics?

Kernal Biologics was founded by Yusuf Erkul.

Q3

Who is the CEO of Kernal Biologics?

The CEO of Kernal Biologics is Yusuf Erkul. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Kernal Biologics raised?

Kernal Biologics has raised a total of $$25 Million across 5 funding rounds. The most recent funding was completed on 2022-07-07.

Q5

Who are the investors in Kernal Biologics?

Kernal Biologics's key investors include Hummingbird Ventures, Amgen Ventures.

Q6

Where is Kernal Biologics headquartered?

Kernal Biologics is headquartered in Cambridge, United States.

Q7

When was Kernal Biologics founded?

Kernal Biologics was founded in 2016.

Q8

How many employees does Kernal Biologics have?

Kernal Biologics has 11-50 employees.

Q9

What is Kernal Biologics's official website?

You can visit Kernal Biologics's official website at http://www.kernalbio.com.

Q10

What was Kernal Biologics's latest funding round?

Kernal Biologics's latest funding round was a Series A round of $$25 Million completed on 2022-07-07.

Q11

Who is founder?

Yusuf Erkul

Q12

What does the company do?

Kernal Biologics develops mRNA therapies for severe diseases, including cancer, using innovative technology to enhance treatment specificity.

Q13

How much funding?

$25 Million

Q14

Latest funding date?

2022-07-07

Q15

Who are the investors?

Hummingbird Ventures Amgen Ventures

Q16

What are the challenges?

Competition in the biotech sector Regulatory approvals for clinical trials

Q17

What are the opportunities?

Advancements in mRNA technology Potential partnerships for research

Q18

Latest news?

Kernal Bio presents its mRNA platform at the Bio€quity Europe 2025 Conference. Kernal Biologics announced the completion of a $25 million Series A financing led by Hummingbird Ventures.

More Information About Kernal Biologics

For additional details about Kernal Biologics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.